Korea Zinc Plans $6.78 Billion U.S. Smelter Investment With Government Partnership 
SpaceX Begins IPO Preparations as Wall Street Banks Line Up for Advisory Roles 
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate 
HSBC’s $13.6 Billion Take-Private Offer for Hang Seng Bank Gains Board Backing 
MetaX IPO Soars as China’s AI Chip Stocks Ignite Investor Frenzy 
Fortescue Expands Copper Portfolio With Full Takeover of Alta Copper 
Korea Zinc to Build $7.4 Billion Critical Minerals Refinery in Tennessee With U.S. Government Backing 
United Airlines Tokyo-Bound Flight Returns to Dulles After Engine Failure 
SUPERFORTUNE Launches AI-Powered Mobile App, Expanding Beyond Web3 Into $392 Billion Metaphysics Market 
Coca-Cola’s Costa Coffee Sale Faces Uncertainty as Talks With TDR Capital Hit Snag 
Coca-Cola’s Proposed Sale of Costa Coffee Faces Uncertainty Amid Price Dispute 
Shell M&A Chief Exits After BP Takeover Proposal Rejected 
Robinhood Expands Sports Event Contracts With Player Performance Wagers 
United Airlines Flight to Tokyo Returns to Dulles After Engine Failure During Takeoff 
Nvidia Weighs Expanding H200 AI Chip Production as China Demand Surges 
iRobot Files for Chapter 11 Bankruptcy Amid Rising Competition and Tariff Pressures 
Blackstone Leads $400 Million Funding Round in Cyera at $9 Billion Valuation 
DENVER, Jan. 19, 2016 (GLOBE NEWSWIRE) -- Morris Animal Foundation, dedicated to improving animal health, has approved funding for 16 new equine research and training grants totaling $1 million. The grants will fund investigators at 13 institutions across the United States, and one each in Switzerland and New Zealand; support 16 university-based studies; and contain three fellowship training grants for new researchers.
The scope of the studies funded covers a diverse set of equine health challenges including infectious diseases, musculoskeletal disorders, respiratory illnesses, and more. Morris Animal Foundation's Equine Scientific Advisory Board reviewed all grant applications and selected, based on scientific merit and impact, the studies that had the greatest potential to advance equine veterinary care and wellness.
Among the grants awarded are:
- How equine muscle cells regulate calcium movement, and the role calcium plays in equine muscle disease. (Dr. Stephanie J. Valberg, University of Minnesota/Michigan State University)
- How to improve diagnosis and treatment of equine insect bite sensitivity, one of the most common allergic skin diseases in horses. (Dr. Eliane Marti, University of Berne)
- Biomechanical forces in different horse gaits as well as genetic risk factors associated with the development of osteochondrosis in Standardbred horses, a breed with a high prevalence of OC lesions. (Dr. Annette M. McCoy, University of Illinois)
- How the bacterium Burkholderia mallei that causes glanders, an infectious disease in horses, regulates immune response to persist in infected animals. (Dr. Sophie A. Aschenbroich, University of Georgia)
- A new treatment strategy against antibiotic-resistant foal pneumonia. (Dr. Steeve Giguère, University of Georgia)
"With the approval of our new set of equine studies, we will continue to improve the health of horses, the treatment tools available for equine veterinarians, and, for horse owners, the hope of having long, healthy lives for their equine companions," said Barb Wolfe, DVM, PhD, chief scientific officer at Morris Animal Foundation. "Each of these studies has the potential to improve the lives of horses in significant ways, and we are incredibly proud to support these enterprising researchers in their endeavors."
About Morris Animal Foundation:
Morris Animal Foundation is a nonprofit organization that invests in science to advance animal health. The foundation is a global leader in funding scientific studies for companion animals, horses and wildlife. Since its founding in 1948, Morris Animal Foundation has invested more than $100 million toward 2,400 studies that have led to significant breakthroughs in diagnostics, treatments, preventions and cures to benefit animals worldwide.
CONTACT: Carol Borchert
[email protected]
303.708.3418
